AKEBIA THERAPEUTICS, INC. Other Intangible Assets, Net
AKEBIA THERAPEUTICS, INC. (AKBA) had Other Intangible Assets, Net of $63.07 million as of 2023-03-31, per its 10-Q filed 2023-05-08.
Discontinued › Notes › Goodwill and Other
us-gaap:OtherIntangibleAssetsNet · last filed 2023-08-28
- 2023-03-31: Other Intangible Assets, Net $63.07M.
- 2022-12-31: Other Intangible Assets, Net $72.08M.
- 2022-09-30: Other Intangible Assets, Net $81.09M.
- 2022-06-30: Other Intangible Assets, Net $90.11M.
| Period end | Other Intangible Assets, Net |
|---|---|
| 2023-03-31 | $63.07M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $72.08M 10-K/A · filed 2023-08-28 |
| 2022-09-30 | $81.09M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $90.11M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $99.12M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $108.13M 10-K/A · filed 2023-08-28 |
| 2021-09-30 | $117.14M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $126.15M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $135.16M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $144.17M 10-K · filed 2022-03-01 |
| 2020-09-30 | $151.38M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $157.48M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $282.11M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $291.21M 10-K · filed 2021-02-25 |
| 2019-09-30 | $300.31M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $309.41M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $318.51M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $328.15M 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |